Jordan Erica
Chief Commercial Officer at Revance Therapeutics, Inc.
- Sold, on record
- $9k
- Dollars the filings state
- Form 4 sales
- 1
- Latest Apr 16, 2024
- Form 144 notices
- 0
- Proposed sales
- Companies
- 1
- Filed as an executive or holder
Companies
- Revance Therapeutics, Inc.Chief Commercial Officer
Sales by reason
0
Routine
0
Plan not stated
0
No plan
0
Unusual
Form 4 sales per month, last 12 months.
Timeline
- 1 Form 4 sale Revance Therapeutics, Inc.No planApr 16, 2024 2024
Sold 2,392 shares at $3.80 ($9k)
Jordan Erica, Chief Commercial Officer
No 10b5-1 planSold 2% of holdings ($446k position)114,864 shares leftFirst sale on recordFiling
Every transaction
Loading transactions…
Sales and notices (1)
| Source | |||||||||
|---|---|---|---|---|---|---|---|---|---|
| Apr 16, 2024 | Apr 17, 2024 | Revance Therapeutics, Inc. | Chief Commercial Officer | Form 4 sale | 2,392 | $9k | 2.0% | No plan | SEC |